Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT04528199 2024-01-16

[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer

Phase 1 Terminated

8 enrolled

Genitourinary

Prostatic Neoplasms

NCT05140512 2023-05-16

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Phase 1 Completed

23 enrolled

Genitourinary

Prostatic Neoplasms

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Phase 1 Unknown

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT03709550 2022-10-05

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT04563936 2021-08-26

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Phase 3 Completed

290 enrolled

Genitourinary

Prostatic Neoplasms

NCT04272645 2020-07-15

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Phase 1 Completed

89 enrolled

BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

NCT02647983 2020-01-22

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

Phase 1 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT02584400 2019-03-08

HX4 SD

Phase 2 Terminated

1 enrolled

CNSGastrointestinalGenitourinary

Hypoxia, Brain Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Rectal Neoplasms

NCT01993160 2017-01-13

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

Phase NA Completed

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT01481441 2016-07-06

AMC_2011_190

Phase NA Terminated

208 enrolled

Genitourinary

Prostatic Neoplasms

NCT00667537 2015-12-14

PK in Pts With HRPC & Skeletal Metastes

Phase 1 Completed

6 enrolled

Genitourinary

Prostatic Neoplasms

NCT01229618 2015-10-05

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

Phase 1 Completed

31 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

THUNDER

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

Spotlight

HRPCa-II

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Study on Human Bioequivalence of Triprerelin Acetate for Injection

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

KEYNOTE F19

[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

HX4 SD

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

AMC_2011_190

PK in Pts With HRPC & Skeletal Metastes

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer